Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02688517 |
|
Recruitment Status :
Recruiting
First Posted : February 23, 2016
Last Update Posted : August 7, 2023
|
Sponsor:
Rutgers, The State University of New Jersey
Collaborators:
National Cancer Institute (NCI)
Rutgers Cancer Institute of New Jersey
Information provided by (Responsible Party):
Shridar Ganesan, MD, PhD, Rutgers Cancer Institute of New Jersey
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2030 |
| Estimated Study Completion Date : | May 2030 |